Bacillus Cereus Peritonitis in a Chronic Peritoneal Dialysis Patient
Bacillus Cereus Peritonitis in a Chronic Peritoneal Dialysis Patient
复制标题
慢性腹膜透析患者的蜡样芽胞杆菌腹膜炎
DOI:
10.1177/089686089701700517
复制
发表时间:
1997
影响因子:
2.8
通讯作者:
T. Chugh
中科院分区:
文献类型:
--
作者:
N. Ai;M. Nampoory;K. Johny;T. Chugh
Editar: Peritonitis continues to be a major problem with maintenance peritoneal dialysis (PD) in the management of patients with end-stage renal failure (ESRF). The common organisms encountered in our cases are gram-positive bacteria in 52.8% and 60.5% for intermittent peritoneal dialysis (IPD) and CAPD peritonitis episodes, respectively (1). We report a very rare instance of Bacillus cereus peritonitis in a patient on IPD. A 65-year-old male patient with ESRF due to diabetic nephropathy had been on IPD for the previous 2 years. He had not experienced any episodes of peritonitis during this period. On 21 May 1995 he presented with one-day duration of abdominal pain and nausea. He vomited once and had two attacks of watery diarrhea. These symptoms occurred a few hours after his regular lunch. Positive findings on physical examination included a temperature of 37.6°C, diffuse abdominal tenderness and rebound. Dialysis fluid was cloudy on inspection. Centrifuged dialysate showed 0.2 x 109/L leukocyte count. Gram-stain smear of the deposit of peritoneal fluid showed many pus cells and gram-positive, long, thick bacilli with central and paracentral spores. The organisms were formed both intra and extracellularly. The spores did not bulge the bodies of the bacilli. The fluid was cultured on blood, MacConkey, and chocolate agars, both aerobically and anaerobically at 37°C overnight. There was a pure heavy growth of large, raised colonies with undulate margins and beta hemolysis. Bacteriologically the organisms were identified as B. cereus. The patient was empirically started on vancomycin (1 g intravenously) and gentamicin (80 mg IV as the loading dose, followed by 8 mg/L of gentamicin intraperitoneally). In the sensitivity study, the organism was susceptible to vancomycin, teicoplanin, clindamycin, and erythromycin but resistant to piperacillin and cephalosporins. The patient improved symptomatically, and peritoneal fluid abnormalities resolved in 24 hours. He was discharged home to complete a course of vancomycin, 1 g weekly for 4 weeks. Follow-up cultures were negative and the patient remained well on IPD. Bacillus cereus has been isolated from a large variety of food items. It may act as a pathogenic species and cause food poisoning after consumption of cooked rice, dried foods, and dairy products in which it has grown and enterotoxin has formed (2). Moreover it may act as a pathogenic species in patients with renal diseases and immunosuppressed patients. In Middle Eastern regions, consumption of cooked rice in large amounts is very popular, and such eating habits may contribute to the incidence of Bacillus infection. Initial antibiotic therapy with vancomycin and gentamicin was successful with this patient because the organism was sensitive to the former drug, an experience which further supports our practice of initial empiric therapy with these two drugs. Bacillus cereus infection complicating maintenance PD is extremely rare. One instance has previously been reported for IPD (3) and two for CAPD (4,5). We recommend that the physician be alert for the possibility of unusual bacterial peritonitis in patients on PD who present with predominant gastrointestinal symptoms.